PII Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
PII is NOT a good buy right now for an impatient buyer. Price is sitting on support (64.07) and looks short-term oversold, but momentum is still bearish (MACD expanding negative) and the latest quarter shows severe profitability deterioration (large loss, EPS -5.34). Options positioning is mixed-to-cautious (OI put/call > 1), and there are no Intellectia buy signals to override the setup. Best call: HOLD (or wait) until price reclaims the pivot (67.5) with improving momentum; otherwise the path of least resistance remains down/sideways near-term.
Intellectia Proprietary Trading Signals
Trend/Momentum: Bearish-to-stabilizing. MACD histogram is -0.719 and negatively expanding, signaling downside momentum is still strengthening. RSI(6) at ~24.4 is effectively oversold (despite the label shown), which often supports a short bounce, but oversold can persist in downtrends.
Levels: Pre-market 64.12 is essentially on S1 support (64.073). A clean break below support increases risk of testing S2 (61.95). Upside resistance is the pivot (67.51) and then R1 (70.94).
Near-term pattern odds: Similar-pattern stats imply ~70% chance of about -1.11% next day, ~+0.52% next week, and ~+3.87% next month—suggesting choppy near-term with mild positive drift longer than a week, but not a high-conviction immediate entry for an impatient buyer.
Dividend catalyst: Board approved a 2% dividend increase to $0.68/share, extending a 31-year dividend-increase streak (confidence/Shareholder-return positive).
Product/news flow: Launch of the all-new limited-run RZR Pro R Ultra Edition (only 500 units) can support brand heat and mix.
Top-line: Q4 2025 adjusted sales +9% YoY, implying market share resilience and some stabilization in retail/dealer inventory commentary from analysts.
Profitability shock: Q4 shows a large net loss and deeply negative EPS, alongside gross margin decline—this is the biggest fundamental overhang.
Post-earnings reaction: Shares fell ~6.5% after Q4 results, indicating investors focused on guidance/quality of earnings.
Demand backdrop: Analyst notes still describe demand as tepid; any macro softness hits discretionary powersports.
No influential-flow support: No notable hedge fund/insider trend cited recently; no congress trading data in the last 90 days; no political/influential buying/selling flagged in the provided data.
Latest quarter: 2025/Q4.
Growth vs profitability: Revenue rose to ~$1.922B (+9.49% YoY), but profitability deteriorated sharply: Net Income fell to about -$303.6M (down ~-2964% YoY) and EPS to -5.34 (down ~-2911% YoY). Gross margin slipped to ~19.99% (down ~1.96% YoY). Net-net: top-line growth is present, but the quality of earnings/margin direction is negative, which typically caps upside until the market sees clearer normalization.
Recent trend: Ratings skew Neutral/Hold/Equal Weight, with one notable Buy.
Wall Street pros vs cons: Pros: Inventory normalization, retail stabilization, and some analysts see undervaluation/earnings power. Cons: Tepid demand, guidance concerns, and heightened uncertainty around margins/profit recovery. Overall Street stance is “wait-and-see” rather than “must-buy now.”
